ACT-001

· RenJi Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-001, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma [NA]

See pricing